Proteomic analysis of microvesicles derived from human colorectal cancer ascites
The presence of malignant ascites in the peritoneal cavity is a poor prognostic indicator of low survival rate. Various cancer cells, including those of colorectal cancer (CRC), release microvesicles (exosomes) into surrounding tissues and peripheral circulation including malignant ascites. Although...
Saved in:
Published in | Proteomics (Weinheim) Vol. 11; no. 13; pp. 2745 - 2751 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
01.07.2011
WILEY‐VCH Verlag Wiley-VCH Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1615-9853 1615-9861 1862-8346 1615-9861 |
DOI | 10.1002/pmic.201100022 |
Cover
Summary: | The presence of malignant ascites in the peritoneal cavity is a poor prognostic indicator of low survival rate. Various cancer cells, including those of colorectal cancer (CRC), release microvesicles (exosomes) into surrounding tissues and peripheral circulation including malignant ascites. Although recent progress has revealed that microvesicles play multiple roles in tumor progression, the protein composition and the pathological function of malignant ascites‐derived microvesicles are still unknown. Here, we report the first global proteomic analyses of highly purified microvesicles derived from human CRC ascites. With 1‐D SDS‐PAGE and nano‐LC‐MS/MS analyses, we identified a total of 846 microvesicular proteins from ascites of three CRC patients with high confidence; 384 proteins were identified in at least two patients. We identified proteins that might function in tumor progression via disruption of epithelial polarity, migration, invasion, tumor growth, immune modulation, and angiogenesis. Furthermore, we identified several potential diagnostic markers of CRC including colon‐specific surface antigens. Our proteomic analyses will help to elucidate diverse functions of microvesicles in cancer progression and will aid in the development of novel diagnostic tools for CRC. |
---|---|
Bibliography: | National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea - No. 0820220 Mid-career Researcher Program through NRF Korea Science and Engineering Foundation (KOSEF) NCRC istex:C0F71339201BE4823A3DF26B2008E80C9CF75436 ark:/67375/WNG-NW56BCNL-T National Research Foundation of Korea ArticleID:PMIC201100022 WCU (World Class University) Korea government (MEST) - No. 2010-0028447 MEST - No. 2009-0080709; No. 2010-0017496 Ministry of Education, Science and Technology - No. R33-10128 These authors contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
ISSN: | 1615-9853 1615-9861 1862-8346 1615-9861 |
DOI: | 10.1002/pmic.201100022 |